Nonclinical diabetes danger components key to post-pandemic care

0
658

Source / information

Published by:

Source:
Healio interview

Disclosure:
Golden and Leffert do not report any relevant financial information.

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

Exclusive in this video, Jonathan D. Leffert, MD, talks to Sherita H. Golden, MD, MHS, on insights into diabetes that she gained on her way to becoming vice president and chief diversity officer for Johns Hopkins Medicine.

Golden describes the overlap of COVID-19 risk factors with those for diabetes and obesity, including prejudice in health systems, lack of diversity among the biomedical workforce, unequal social conditions and structural racism.

ADD SUBJECT TO EMAIL ALARMS

Receive an email when new articles are published

Please enter your email address to receive an email when new articles are published . “data-action =” subscribe “> subscribe

We could not process your request. Please try again later. If you continue to have this problem, please contact customerservice@slackinc.com.

Back to Healio

COVID-19 Resource Center

COVID-19 Resource Center